These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19809796)

  • 1. Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.
    Rudovich N; Pivovarova O; Fisher E; Fischer-Rosinsky A; Spranger J; Möhlig M; Schulze MB; Boeing H; Pfeiffer AF
    J Mol Med (Berl); 2009 Nov; 87(11):1145-51. PubMed ID: 19809796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.
    Bartl J; Scholz CJ; Hinterberger M; Jungwirth S; Wichart I; Rainer MK; Kneitz S; Danielczyk W; Tragl KH; Fischer P; Riederer P; Grünblatt E
    BMC Med Genet; 2011 Nov; 12():151. PubMed ID: 22107728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of insulin degrading enzyme activity and liver cell proliferation.
    Pivovarova O; von Loeffelholz C; Ilkavets I; Sticht C; Zhuk S; Murahovschi V; Lukowski S; Döcke S; Kriebel J; de las Heras Gala T; Malashicheva A; Kostareva A; Lock JF; Stockmann M; Grallert H; Gretz N; Dooley S; Pfeiffer AF; Rudovich N
    Cell Cycle; 2015; 14(14):2293-300. PubMed ID: 25945652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study.
    Karamohamed S; Demissie S; Volcjak J; Liu C; Heard-Costa N; Liu J; Shoemaker CM; Panhuysen CI; Meigs JB; Wilson P; Atwood LD; Cupples LA; Herbert A;
    Diabetes; 2003 Jun; 52(6):1562-7. PubMed ID: 12765971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms of the insulin-degrading enzyme gene and late-onset Alzheimer disease.
    Wang S; He F; Wang Y
    J Geriatr Psychiatry Neurol; 2015 Jun; 28(2):94-8. PubMed ID: 25414272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people.
    Florez JC; Wiltshire S; Agapakis CM; Burtt NP; de Bakker PI; Almgren P; Bengtsson Boström K; Tuomi T; Gaudet D; Daly MJ; Hirschhorn JN; McCarthy MI; Altshuler D; Groop L
    Diabetes; 2006 Jan; 55(1):128-35. PubMed ID: 16380485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population.
    Kwak SH; Cho YM; Moon MK; Kim JH; Park BL; Cheong HS; Shin HD; Jang HC; Kim SY; Lee HK; Park KS
    Diabetes Res Clin Pract; 2008 Feb; 79(2):284-90. PubMed ID: 17913278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility.
    Groves CJ; Wiltshire S; Smedley D; Owen KR; Frayling TM; Walker M; Hitman GA; Levy JC; O'Rahilly S; Menzel S; Hattersley AT; McCarthy MI
    Diabetes; 2003 May; 52(5):1300-5. PubMed ID: 12716770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels.
    Gu HF; Efendic S; Nordman S; Ostenson CG; Brismar K; Brookes AJ; Prince JA
    Diabetes; 2004 Aug; 53(8):2137-42. PubMed ID: 15277398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of postprandial insulin clearance control by Insulin-degrading enzyme drives dysmetabolism traits.
    Borges DO; Patarrão RS; Ribeiro RT; de Oliveira RM; Duarte N; Belew GD; Martins M; Andrade R; Costa J; Correia I; Boavida JM; Duarte R; Gardete-Correia L; Medina JL; Raposo JF; Jones JG; Penha-Gonçalves C; Macedo MP
    Metabolism; 2021 May; 118():154735. PubMed ID: 33631143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort.
    Pivovarova O; Nikiforova VJ; Pfeiffer AF; Rudovich N
    Diabetes Metab Res Rev; 2009 Feb; 25(2):156-62. PubMed ID: 19117022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.
    Mueller JC; Riemenschneider M; Schoepfer-Wendels A; Gohlke H; Konta L; Friedrich P; Illig T; Laws SM; Förstl H; Kurz A
    Neurobiol Aging; 2007 May; 28(5):727-34. PubMed ID: 16675064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies.
    Ruchat SM; Elks CE; Loos RJ; Vohl MC; Weisnagel SJ; Rankinen T; Bouchard C; Pérusse L
    Acta Diabetol; 2009 Sep; 46(3):217-26. PubMed ID: 19082521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
    Tang WJ
    Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphism rs2421943 of the insulin-degrading enzyme and schizophrenia: Preliminary report.
    Ambrozová L; Zeman T; Janout V; Janoutová J; Lochman J; Šerý O
    J Clin Lab Anal; 2023 Jul; 37(13-14):e24949. PubMed ID: 37515308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
    Nordman S; Ostenson CG; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population.
    Sakai A; Ujike H; Nakata K; Takehisa Y; Imamura T; Uchida N; Kanzaki A; Yamamoto M; Fujisawa Y; Okumura K; Kuroda S
    Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):87-91. PubMed ID: 14755451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
    Blomqvist ME; Chalmers K; Andreasen N; Bogdanovic N; Wilcock GK; Cairns NJ; Feuk L; Brookes AJ; Love S; Blennow K; Kehoe PG; Prince JA
    Neurobiol Aging; 2005 Jun; 26(6):795-802. PubMed ID: 15718037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
    Nowotny P; Hinrichs AL; Smemo S; Kauwe JS; Maxwell T; Holmans P; Hamshere M; Turic D; Jehu L; Hollingworth P; Moore P; Bryden L; Myers A; Doil LM; Tacey KM; Gibson AM; McKeith IG; Perry RH; Morris CM; Thal L; Morris JC; O'Donovan MC; Lovestone S; Grupe A; Hardy J; Owen MJ; Williams J; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):62-8. PubMed ID: 15858813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.